Back to Search
JAMIE MCCRACKEN, APRN
APRN
Psychiatric/Mental Health Nurse Practitioner
NPI: 1750991592IndividualAccepts Medicare
Specialties, Licenses & Credentials
Psychiatric/Mental Health Nurse PractitionerPrimary
Nurse Practitioner — Psychiatric/Mental Health
Code: 363LP0808X
RN246546(GA)RN246456(GA)
CMS Specialties
PrimaryNURSE PRACTITIONER
Education
OTHER
Class of 2019
Clinical Trials (2)
2
Linked Trials
0
Recruiting
2
With Results
Research & Publications (10)
Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD).
PMID 41342306·Cochrane Database Syst Rev·2025
1-meta
Pharmacological intervention for irritability, aggression, and self-injury in autism spectrum disorder (ASD).
PMID 37811711·Cochrane Database Syst Rev·2023
1-meta
Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD).
PMID 36971690·Cochrane Database Syst Rev·2023
1-meta
Electrophysiological and Clinical Predictors of Methylphenidate, Guanfacine, and Combined Treatment Outcomes in Children With Attention-Deficit/Hyperactivity Disorder.
PMID 35963559·J Am Acad Child Adolesc Psychiatry·2023
2-rct
Methylphenidate, Guanfacine, and Combined Treatment Effects on Electroencephalography Correlates of Spatial Working Memory in Attention-Deficit/Hyperactivity Disorder.
PMID 35963558·J Am Acad Child Adolesc Psychiatry·2023
2-rct
Acute and Long-Term Cardiovascular Effects of Stimulant, Guanfacine, and Combination Therapy for Attention-Deficit/Hyperactivity Disorder.
PMID 27483130·J Child Adolesc Psychopharmacol·2016
4-observational
Effects of d-Methylphenidate, Guanfacine, and Their Combination on Electroencephalogram Resting State Spectral Power in Attention-Deficit/Hyperactivity Disorder.
PMID 27453081·J Am Acad Child Adolesc Psychiatry·2016
2-rct
Cognitive Effects of Stimulant, Guanfacine, and Combined Treatment in Child and Adolescent Attention-Deficit/Hyperactivity Disorder.
PMID 27453080·J Am Acad Child Adolesc Psychiatry·2016
2-rct
Combined Stimulant and Guanfacine Administration in Attention-Deficit/Hyperactivity Disorder: A Controlled, Comparative Study.
PMID 27453079·J Am Acad Child Adolesc Psychiatry·2016
4-observational
A prospective open trial of guanfacine in children with pervasive developmental disorders.
PMID 17069547·J Child Adolesc Psychopharmacol·2006
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2538 GORDON CIR SE
SMYRNA, GA 30080 - Phone
- (404) 775-1276
Quick Facts
- NPI
- 1750991592
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 7
- Clinical Trials
- 2
- Publications
- 10
Are you this provider?
Claim Your Profile